Home Page | Lorbrena® (lorlatinib) Official Patient Site | Safety Info
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
How It Works | Lorbrena® (lorlatinib) Patient Site | Safety Info
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
Side Effects | Lorbrena® (lorlatinib) Patient Site | Safety Info
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
About ALK+ NSCLC | Lorbrena® (lorlatinib) Patient Site | Safety Info
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
about-lorbrena
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
6 7 LORBRENA® (lorlatinib) may cause serious side effects, including: • Liver problems due to interactions with other medicines. It is important to know what medicines should not be taken …
PATIENT FINANCIAL ASSISTANCE - Lorbrena
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
LORBRENA® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …
IMPORTANT SAFETY INFORMATION 4 LORBRENA® (lorlatinib) may cause serious side effects, including: • Liver problems due to interactions with other medicines. It is important to …
SHARE YOUR STORY - Lorbrena
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene …